Anagallis Arvensis

ANAGALLIS ARVENSIS ORAL HUMAN OTC DRUG

Anagallis Arvensis is an FDA drug label for the active ingredient ANAGALLIS ARVENSIS manufactured by Hahnemann Laboratories, INC. administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20230802.

Generic name
ANAGALLIS ARVENSIS
Manufacturer
Hahnemann Laboratories, INC.
Product type
HUMAN OTC DRUG
Route
ORAL
Dosage form
N/A
NDC
37662-3664
Application
N/A
Label effective
20230802

Active ingredients

Indications & Usage

Not available.

Dosage & Administration

Not available.

Contraindications

Not available.

Warnings

Not available.

Adverse Reactions

Not available.